(Mis)treating the pharmacogenetic incidentalome.

Abstract excerpt

Genome-wide screening is anticipated to accelerate the development of personalized medicine by identifying and exploiting new associations between genomic variants and drug responses. However, this goal could be undermined if care is not taken to minimize the impact of pharmacogenomic associations that turn out to have narrower implications than suggested by initial studies.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug-Related Side Effects and Adverse Reactions
• Share to Genetic Predisposition to Disease
• Share to Incidental Findings